Cathy Burgess spoke at the “COVID-19 and Beyond: Development and Implementation of Recovery Action Plans for Medical Product Manufacturers” live webinar sponsored by the Food and Drug Law Institute (FDLI). The webinar explored unanticipated supply chain disruptions and postponed FDA inspections that have created significant risks and challenges for the global medical product manufacturing network, how to implement and manage an effective plan, and how to be prepared for an establishment inspection. Cathy spoke on recent regulatory and legislative developments related to post-COVID-19 recovery action plans, as well as strategies for developing them.
For more information, click here.